Journals / Cukurova Medical Journal / 2022 / Cilt: 47 - Sayı: 2

Impact of gossypin on gene expression of HSP60 and HSP70 in different cancer cell lines

Gossypin'in farklı kanser hücre dizilerinde HSP60 ve HSP70'in gen ekspresyonu üzerindeki etkisi

Pages
497–503
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our findings suggest that gossypin could be suitable candidate agent for further investigation to develop new strategies for the prevention and/or treatment of different cancer types.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study is to evaluate the impact of gossypin on the expression level of heat shock proteins (HSPs) genes in different cancer cells.
📊
Key Findings & Data:Cancer cells were treated with different concentrations (5-100 µg/ml) of gossypin and cisplatin (50 µM) as positive control.
💡
Conclusion & Impact:Our findings suggest that gossypin could be suitable candidate agent for further investigation to develop new strategies for the prevention and/or treatment of different cancer types.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of this study is to evaluate the impact of gossypin on the expression level of heat shock proteins (HSPs) genes in different cancer cells. Materials and Methods: Cells were grown under standard culture conditions. Cancer cells were treated with different concentrations (5-100 µg/ml) of gossypin and cisplatin (50 µM) as positive control. Cell viability and effective dose range (5-100 µg/ml) of gossypin were determined by MTT at 24, 48 and 72 hours. After RNA isolation and cDNA synthesis, HSP60 and HSP70 gene expression levels were analyzed using RT-PCR. For gene expression analysis, the 2-∆∆ct method was used. Results: According to the MTT results, 25-50-100 µg/ml of gossypin doses were found effective on HSP60 and HSP70 gene expression levels in the cancer cell lines. Gossypin affected with dose-dependently the expression of HSP60 and HSP70 in the three cell lines. In the three cell lines, 50 µg/ml and 100 µg/ml of gossypin doses significantly reduced the expression of HSP60 and HSP70 compared to control group. Conclusion: Our results strongly supported the anticarcinogenic effect of gossypin at various doses in different cell lines. However, we believe that further in vivo research and human studies are needed. Our findings suggest that gossypin could be suitable candidate agent for further investigation to develop new strategies for the prevention and/or treatment of different cancer types.

Özet

Amaç: Bu çalışmanın amacı, gossypin'in farklı kanser hücre hatlarında ısı şok proteinleri (HSP) genlerinin ekspresyon seviyesi üzerindeki etkisini incelemektir. Gereç ve Yöntem: Hücreler, standart kültür koşulları altında büyütüldü. Kanser hücreleri, farklı konsantrasyonlarda (5-100 µg/ml) gossypin ve pozitif kontrol olarak sisplatin (50 µM) ile muamele edildi. Gossypin'in hücre canlılığı ve etkili doz aralığı (5-100 µg/ml), 24, 48 ve 72. saatlerde MTT ile belirlendi. RNA izolasyonu ve cDNA sentezinden sonra, HSP60 ve HSP70 gen ekpresyon seviyesi RT-PCR ile analiz edildi. Gen ekspresyonu için 2-∆∆ct methodu kullanıldı. Bulgular: MTT sonuçlarına göre kanser hücre hatlarında 25-50-100 µg/ml gossipin dozlarının HSP60 ve HSP70 gen ekspresyon seviyeleri üzerinde etkili olduğu bulundu. Gossypin, üç hücre hattında HSP60 ve HSP70'in ekspresyonunu doza bağımlı olarak etkilemiştir. Üç hücre hattında, 50 µg/ml ve 100 µg/ml gossipin dozları, HSP60 ve HSP70'in ekspresyonunu kontrol grubuna kıyasla önemli ölçüde azalttı. Sonuç: Sonuçlarımız, farklı hücre dizilerinde çeşitli dozlarda gossypinin antikarsinojenik etkisini güçlü bir şekilde desteklemektedir. Fakat, daha fazla in vivo araştırma ve insan çalışmalarına ihtiyaç olduğuna inanıyoruz. Bulgularımız, gossypin'nin farklı kanser türlerinin önlenmesi ve/veya tedavisi için yeni stratejiler geliştirmek için daha ileri araştırmalar için uygun aday ajan olabileceğini düşündürmektedir.

🔖

Cite This Article

DİRİCAN, E., ÇINAR, İ. (2022). Impact of gossypin on gene expression of HSP60 and HSP70 in different cancer cell lines. Cukurova Medical Journal, Cilt: 47 - Sayı: 2, 497–503. https://ajindex.com/articles/476755

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as Anticancer Agents. Nutrients. 2020;12(2):457
  2. Kapoor M, Kaur G, Kaur N, Sharma C, Batra K, Singh D. The Traditional Uses, Phytochemistry and Pharmacology of Genus Hibiscus: A Review. European J Med Plants. 2021:1–37
  3. Chandrashekhar VM, Ganapaty S, Ramkishan A, Narsu MlL. Neuroprotective activity of gossypin from Hibiscus vitifolius against global cerebral ischemia model in rats. Indian J Pharmacol. 2013;45(6):575–80
  4. Wang L, Wang X, Chen H, et al. Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2. Phyther Res. 2018:ptr.6253
  5. Patel K, Kumar V, Verma A, Patel DK. Gossypin: A phytochemical of multispectrum potential. J Coast Life Med. 2017:365–70
  6. Ganapaty S, Chandrashekhar V, Chitme H, Narsu Ml. Free radical scavenging activity of gossypin and nevadensin: An in-vitro evaluation. Indian J Pharmacol. 2007;39(6):281
  7. Khlebnikov AI, Schepetkin IA, Domina NG, Kirpotina LN, Quinn MT. Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems. Bioorg Med Chem. 2007;15(4):1749–70
  8. Rasilingam D, Duraisamy S, Subramanian R. Anticonvulsant activity of bioflavonoid gossypin. Bangladesh J Pharmacol. 2008;4(1)
  9. Babu BH, Jayram HN, Nair MG, Ajaikumar KB, Padikkala J. Free radical scavenging, antitumor and anticarcinogenic activity of gossypin. J Exp Clin Cancer Res. 2003;22(4):581–9
  10. Prabhakaran D, Rajeshkanna A, Senthamilselvi M. In vitro Anticancer Activity of Hibiscus vitifolius Flowers Ethyl Acetate Fraction against Hepg2 Cell Line. Br J Pharm Res. 2016;9(5):1–5
  11. ÇINAR İ, YAYLA M, BİNNETOĞLU D. Gossypinin insan hepatom (Hep-3B) hücreleri üzerinde anti-proliferatif etkisi. Cukurova Med J. 2020;45(3):1165–72
  12. Kunnumakkara AB, Nair AS, Ahn KS, et al. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-κB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. Blood. 2007;109(12):5112–21
  13. Yildiz MT, Tutar L, Giritlioğlu NI, Bayram B, Tutar Y. MicroRNAs and Heat Shock Proteins in Breast Cancer Biology. Methods Mol Biol. 2022;2257:293–310
  14. Liu T, Daniels CK, Cao S. Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential. Ph